top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
President Donald Trump issued an executive order to accelerate federal research into psychedelic treatments like ibogaine for veterans with PTSD and traumatic brain injuries. Supported by Joe Rogan and Robert F. Kennedy Jr., the move signals a shift in federal drug policy that advocates believe could eventually benefit cannabis rescheduling and research.

New Federal Push for Psychedelic Research Might Just Clear the Path for Cannabis Too

Apr 18, 2026

Source:

Cannabis Now

Cannabis Now

The federal government is finally pulling back the curtain on alternative therapies, and the implications for the cannabis community are massive. On April 18, just in time for the 4/20 festivities, a new executive order was signed in the Oval Office aimed at fast-tracking research into psychedelic treatments. While the primary focus is on helping our veterans manage PTSD and traumatic brain injuries, this move signals a major crack in the federal government’s long-standing wall against Schedule I substances.

With heavy hitters like Joe Rogan and RFK Jr. standing by, the administration highlighted ibogaine—a compound from West Africa—as a potential game-changer for those dealing with trauma and addiction. For years, our brothers and sisters in arms have had to travel to places like Mexico to find relief. Now, Washington is finally directing federal agencies to clear the bureaucratic hurdles and get real clinical studies moving right here at home.

So, why does this have the cannabis world buzzing? It’s simple: consistency. For years, the government has ignored the mountains of evidence showing how cannabis helps veterans sleep, manage pain, and ease anxiety. By officially supporting accelerated research into one Schedule I plant for mental health, they’ve made it nearly impossible to keep ignoring another. As industry experts are pointing out, this creates a "domino effect." Once you align policy with the reality of plant medicine, the push for full cannabis rescheduling becomes an unstoppable force.

For everyday enthusiasts and medical patients, this is a huge win for accessibility. It means we’re moving away from outdated stigmas and toward a future where safe, lab-tested natural options are treated with respect. While this order doesn't change the law overnight, it’s a powerful green light for the scientific community. If you’ve been waiting for the feds to catch up to what we’ve known for years, this is the momentum we’ve been looking for. It’s a great time to be a part of this community—stay optimistic and keep supporting your local dispensaries!

Recent Reviews

bottom of page